内科学第二
論文
A 欧文
A-a
1. Soda H, Ogawara D, Fukuda Y, Tomono H, Okuno D, Koga S, Taniguchi H, Yoshida M, Harada T, Umemura A, Yamaguchi H,
Mukae H: Dynamics of blood neutrophil-related indices during nivolumab treatment may be associated with response to salvage
chemotherapy for non-small cell lung cancer: A hypothesis-generating study. Thorac Cancer 10(2): 341-346, 2019 (IF:2.569) ＊2. Taniguchi H, Yamada T, Wang R, Tanimura K, Adachi Y, Nishiyama A, Tanimoto A, Takeuchi S, Araujo LH, Boroni M,
Yoshimura A, Shiotsu S, Matsumoto I, Watanabe S, Kikuchi T, Miura S, Tanaka H, Kitazaki T, Yamaguchi H, Mukae H, UchinoJ, Uehara H, Takayama K, Yano S: AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
Nat Commun 10(1): 259, 2019 (IF:12.353) ＊3. Mizuta S, Tagod MSO, Iwasaki M, Nakamura Y, Senju H, Mukae H, Morita CT, Tanaka Y: Synthesis and Immunomodulatory
Activity of Fluorine-Containing Bisphosphonates. ChemMedChem 14(4): 462-468, 2019 (IF:3.009) ＊4. Tagod MSO, Mizuta S, Sakai Y, Iwasaki M, Shiraishi K, Senju H, Mukae H, Morita CT, TanakaY: Determination of human γ
δT cell-mediated cytotoxicity using a non-radioactive assay system. J Immunol Methods 466: 32-40, 2019 (IF:2.19) ＊5. Takemoto S, Nakamura Y, Gyoutoku H, Senju H, Ogawara D, Ikeda T, Yamaguchi H, Kitazaki T, Nakano H, Nakatomi K,
Tomari S, Sato S, Nagashima S, Fukuda M, Mukae H: Phase II trial of a non-platinum triplet for patients with advanced nonsmall cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA. Thorac Cancer 10(3): 452-459, 2019 (IF:2.569) ＊○6. Ideguchi S, Yamamoto K, Ikeda A, Hashimoto K, Takazono T, Saijo T, Imamura Y, Miyazaki T, Mukae H: A case of bilateralemphysematous pyelonephritis caused by Candida albicans. J Infect Chemother 25: 302-306, 2019. (IF:1.539) ＊7. Takazono T, Saijo T, Ashizawa N, Oshima K, Nishimura K, Tashiro M, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K,
Mukae H, Izumikawa I, Donald C. Sheppard: Clinical features and cause analysis of false positive results of Aspergillus
galactomannan assay in pulmonary. Eur J Clin Microbiol Infect Dis 38: 735-741, 2019 (IF:2.537) ＊8. Kitamura M, Hisano S, Kurobe Y, Abe S, Ota Y, Sawayama Y, Uramatsu T, Obata Y, Fukuoka J, Miyazaki Y, Mukae H, Nishino
T: Membranous nephropathy with crescent after hematopoietic cell transplantation. Intern Med 58(1): 91-96, 2019 (IF:0.956) ＊9. Minematsu A, Miyazaki T, Shimamura S, Nishikawa H, Nakayama H, Takazono T, Saijo T, Yamamoto K, Imamura Y,
Yanagihara K, Kohno S, Mukae H, Izumikawa K: Vacuolar proton-translocating ATPase is required for antifungal resistance andvirulence of Candida glabrata. PLOS ONE 14(1): e0210883, 2019 (IF:2.776) ＊○★
10. Shimamura S, Miyazaki T, Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S,
Mukae H: Autophagy-inducing factor Atg1 is required for virulence in the pathogenic fungus. Front Microbiol 10: 27, 2019
(IF:4.259) ＊★
11. Kitamura M, Obata Y, Ota Y, Muta K, Yamashita H, Harada T, Makae H, Nishino T: Significance of subepithelial deposits inpatients diagnosed with IgA nephropathy. PLOS ONE 14(2): e0211812, 2019 (IF:2.776) ＊12. Yamakawa H, Kosai K, Akamatsu N, Matsuda J, Kaku N, Uno N, Morinaga Y, Hasegawa H, Tsubouchi T, Keneko Y, Miyazaki
T, Izumikawa K, Mukae H, Yanagihara K: Molecular and epidemiological analysis of IMP-1 metallo-β-lactamase-producing
Klebsiella pneumoniae in a tertiary care hospital in Japan. J Infect Chemother 25(4): 240-246, 2019 (IF:1.539) ＊13. Noguchi S, Yatera K, Naito K, Hata R, Kawanami T, Yamasaki K, Kato T, Orihashi T, Inoue N, Sakamoto N, Yoshii C, Mukae
H: Utility of the Quick Sequential Organ Failure Assessment in Japanese patients with nursing- and healthcare-associatedpneumonia. Geriatr Gerontol Int 16(3): 177-183, 2019 (IF:2.118) ＊14. Sawai T, Koga S, Ide S, Yoshioka D, Matsuo N, Mukae H: An iliopsoas abscess caused by Parvimonas micra: a case report. J
Med Case Rep 13(1): 47, 2019－15. Hanaka T, Kido T, Ishimoto H, Oda K, Noguchi S, Nawata A, Nakayamada S, Sakamoto N, Tanaka Y, Yatera K, Mukae H:
Radiological patterns of pulmonary involvement may predict treatment response in rheumatoid arthritis: a retrospective study.
Respir Investig 57(2): 172-182, 2019－16. Sakamoto N, Ishimoto H, Nakashima S, Yura H, Miyamura T, Okuno D, Hara A, Kitazaki T, Kakugawa T, Ishimatsu Y, SatohM, Mukae H: Clinical features of anti-MDA5 antibody positive rapidly progressive interstitial lung disease without signs ofdermatomyositis. Intern Med 58(6): 837-841, 2019 (IF:0.956) ＊17. Uchimura K, Yamasaki K, Hirano Y, Sakagami K, Kido T, Mukae H, Yatera K: The successful removal of a broken needle as
an unusual complication of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): A case report andliterature review. J UOEH 41(1): 35-40, 2019－1

18. Fukuda M, Kitazaki T, Ogawara D, Ichiki M, Mukae H, Maruyama R, Nakagaki N, Shimada M, Ikeda T, Kishimoto J, Harada
T, Seto T, Ebi N, Takayama K, Okamoto I, Ichinose Y, Sugio K: Randomized phase II study of pemetrexed or pemetrexed plus
bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung
Oncology Group in Kyushu (LOGIK1201). Lung Cancer 132: 1–8, 2019 (IF:4.486) ＊19. Mori M, Hayashi H, Fukuda M, Honda S, Kitazaki T, Shigematsu K, Matsuyama N, Otsubo M, Nagayasu T, Hashisako M,
Tabata K, Uetani M & Ashizawa K: Clinical and computed tomography characteristics of nonsmall cell lung cancer with ALK
gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer. Thorac Cancer 10(4): 872–879,
2019 (IF:2.569) ＊20. Takazono T, Ito Y, Tashiro M, Nishimura K, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H,
Izumikawa K: Evaluation of Aspergillus-Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for
Diagnosis of Chronic Pulmonary Aspergillosis. J Clin Microbiol 57(5): e00095-19, 2019 (IF:4.054) ＊21. Nakamichi S, Origuchi T, Fukui S, Yoda A, Matsubara H, Nagaura Y, Nishikomori R, Abe K, Migita K, Sakamoto N, Kawakami
A, Ozono Y, Maeda T: A Rare Case of Cryopyrin-associated Periodic Syndrome in an Elderly Woman with NLRP3 and MEFV
Mutations. Intern Med 58(7): 1017-1022, 2019 (IF:0.956) ＊22. Fukuda K, Takeuchi S, Arai S, Katayama R, Nanjo S, Tanimoto A, Nishiyama A, Nakagawa T, Taniguchi H, Suzuki T, Yamada
T, Nishihara H, Ninomiya H, Ishikawa Y, Baba S, Takeuchi K, Horiike A, Yanagitani N, Nishio M, Yano S: Epithelial-toMesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status.
Cancer Res 79(7): 1658-1670, 2019 (IF:9.13) ＊23. Nakamura S, Iwanaga N, Hara S, Shimada S, Kashima Y, Hayasakai D, Abe K, Izumikawa K, Yanagihara K, Miyazaki Y, Morita
K, Kohno S, Mukae H: Viral load and inflammatory cytokine dynamics associated with the prognosis of severe fever withthrombocytopenia syndrome virus infection: An autopsy case. J Infect Chemoth 25(6): 480-484, 2019 (IF:1.539) ＊24. Kitamura M, Mochizuki Y, Kitamura S, Mukae Y, NaKanishi H, Ota Y, Muta K, Yamashita H, Obata Y, Iwata T, Nishikido M,
Kawanami S, Takashima M, Sasaki H, Sakai H, Mukae H, Nishino T, Prediction of nonadherence and renal prognosis by pretransplantation serum phosphate levels. Ann Transplnant 24: 260-267, 2019 (IF:1.369) ＊25. Li L, Foo BJW, Kwok KW, Sakamoto N, Mukae H, Izumikawa K, Mandard S, Quenot JP, Lagrost L, Teh WK, Singh Kohli G,
Zhu P, Choi H, Buist ML, Seet JE, Yang L, He F, Kwong Chow VT, Tan NS: Antibody Treatment against Angiopoietin-Like 4
Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia. mBio 10(3): e02469-18, 2019 (IF:6.689) ＊26. Ng CFS, Hashizume M, Obase Y, Doi M, Tamura K, Tomari D, Kawano T, Fukushima C, Matsuse H, Chung Y, Kim Y,
Kunimitsu K, Kohno S, Mukae H: Associations of chemical composition and sources of PM2.5 with lung function of severe
asthmatic adults in a low air pollution environment of urban Nagasaki, Japan. Environ Pollut 252: 599-606, 2019 (IF:5.714) ＊27. Kitamura M, Tateishi Y, Sato S, Kitamura S, Ota Y, Muta K, Yamashita H, Uramatsu T, Obata Y, Mochizuki Y, Nishikado M,
Izumo T, Harada T, Funakoshi S, Matsuo T, Tsujino A, Sasaki H, Mukae H, Nishino T: Association between serum calcium
levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis. BMC Nephrol20(1): 210, 2019 (IF:2.088) ＊28. Ashizawa N, Miyazaki T, Abe S, Takazono T, Saijo T, Obata Y, Shimamura S, Yamamoto K, Imamura Y, Koji T, Nishino T,
Izumikawa K, Yanagihara K, Kohno S, Mukae H: Evaluation of Candida peritonitis with underlying peritoneal fibrosis andefficacy of micafungin in murine models of intra-abdominal candidiasis. Sci Rep 9 (1): 9331, 2019 (IF:4.011) ＊○★
29. Ikeda S, Koga S, Yamagata Y, Koide Y, Kawano H, Mukae H, Maemura K: Pulmonary thromboembolism caused by calcificationin the inferior vena cava of a Japanese adult. Intern Med 58(13): 1907-1912, 2019 (IF:0.956) ＊30. Akata K, Muratani T, Yatear K, Naito K, Noguchi S, Yamasaki K, Kawanami T, Kido T, Mukae H: Induction of plasmidmediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae. PLoS One 14(7):e0218589, 2019 (IF:2.776) ＊31. Miyamura T, Sakamoto N, Kakugawa T, Okuno D, Yura H, Nakashima S, Ishimoto H, Kido T, Taniguchi D, Miyazaki T,
Tsuchiya T, Tsutsui S, Yamaguchi H, Obase Y, Ishimatsu Y, Ashizawa K, Nagayasu T, Mukae H: Postoperative acuteexacerbation of interstitial pneumonia in pulmonary and non-pulmonary surgery: a retrospective study. Respir Res 20(1): 154,2019 (IF:3.829) ＊32. Wang R, Yamada T, Arai S, Fukuda K, Taniguchi H, Tanimoto A, Nishiyama A, Takeuchi S, Yamashita K, Ohtsubo K, Matsui
J, Onoda N, Hirata E, Taira S, Yano S: Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic
Thyroid Cancer Cells in Severe Combined Immune Deficient Mice. Mol Cancer Ther 18(5): 947-956, 2019. (IF:5.365) ＊★
33. Fukahori S, Kawano T, Obase Y, Umeyama Y, Sugasaki N, Kinoshita A, Fukushima C, Yamakawa M, Omagari K, Mukae H:
Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use. Am J Case Rep 20: 1124-1127, 2019
(IF:0.69) ＊34. Shimoda T, Obase Y, Nagasaka Y, Kishikawa R, Iwanaga T: Lung Sound Analysis and the Respiratory Cycle Dependence of
Impulse Oscillometry in Asthma Patients. Intern Med 58(1): 47-52, 2019 (IF:0.956) ＊2

35. Fukumitsu T, Obase Y, Ishimatsu Y, Nakashima S, Ishimoto H, Sakamoto N, Nishitsuji K, Shiwa S, Sakai T, Miyahara S,
Ashizawa K, Mukae H, Kozu R: The acoustic characteristics of fine crackles predict honeycombing on high-resolution computed
tomography. BMC Pulm Med 19(1): 153, 2019 (IF:2.184) ＊36. Sakamoto N, Hara S, Ishimoto H, Nakashima S, Yura H, Miyamura T, Okuno D, Hara A, Kakugawa T, Yamaguchi H, Obase Y,
Kushima H, Ishii H, Noguchi S, Kido T, Kobayashi T, Soejima Y, Yoshioka S, Ishimatsu Y, Yatera K, Kadota JI, Mukae H:
Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid
Arthritis under Methotrexate Therapy. Tohoku J Exp Med 248: 209-216, 2019 (IF:1.584) ＊37. Yamashita K, Miyazaki T, Fukuda Y, Mitsuyama J, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara
K, Kohno S, Mukae H: The novel arylamidine T-2307 selectively disrupts yeast mitochondrial function by inhibiting respiratory
chain complexes. Antimicrob Agents Chemother 63(8): e00374-19, 2019 (IF:4.715) ＊38. Miyazaki T, Fukushima K, Hashiguchi K, Inoue Y, Mihara T, Sawai T, Suyama N, Kobayashi T, Kondo A, Fukuda Y, Harada
Y, Sasaki E, Kaku N, Ide S, Takazono T, Saijo T, Koasi K, Morinaga Y, Nakamura S, Yamamoto K, Imamura Y, Izumikawa K,
Yanagihara K, Kohno S, Mukae H: Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary
disease: a prospective multicenter interventional study. J Infect Chemother 25: 702-707, 2019 (IF:1.539) ＊39. Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M,
Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki
S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T,
Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M,
Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi
M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K,
Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M,
Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M:
Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of
Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014:
General view of the pathogens' antibacterial susceptibility. J Infect Chemoth 25(9): 657-668, 2019 (IF:1.539) ＊40. Tahara M, Oda K, Yamasaki K, Kawaguchi T, Sennari K, Noguchi D, Sakamoto N, Kawanami T, Mukae H, Yatera K: Temporalechocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib withor without oxygen therapy. BMC Pulm Med 19(1): 157, 2019 (IF:2.184) ＊41. Taniguchi H, Yamaguchi H, Dotsu Y, Shimada M, Gyotoku H, Senju H, Takemoto S, Kitazaki T, Fukuda M, Ogawara D, Soda
H, Nakatomi K, Sugasaki N, Kinoshita A, Nagashima S, Ikeda T, Nakamura Y, Sakamoto N, Obase Y, Fukuda M, Mukae H:
Phase Ⅱ study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancer. Thorac Cancer 10(9):1764-1769, 2019 (IF:2.569) ＊42. Iwanaga H, Yamamoto K, Takazono T, Saijo Y, Imamura Y, Miyazaki T, Izumikawa K, Yamamoto Y, Yanagihara K, Yasuoka
A, Mukae H: Munchausen syndrome mimicking refractory subcutaneous abscess with bacteremia, diagnosed by repetitiveelement sequence-based polymerase chain reaction: a case report. J Med Case Rep 13(1): 287, 2019 (IF:0.58) ＊43. Ueda T, Takesue Y, Tokimatsu I, Miyazaki T, Nakada-Motokawa N, Nagao M, Nakajima K, Mikamo H, Yamagishi Y, Kasahara
K, Yoshihara S, Ukimura A, Yoshida K, Yoshinaga N, Izumi M, Kakeya H, Yamada K, Kawamura H, Endou K, Yamanaka K,
Yoshioka M, Amino K, Ikeuchi H, Uchino M, Miyazaki Y: The incidence of endophthalmitis or macular involvement and thenecessity of a routine ophthalmic examination in patients with candidemia. PLoS One 14(5): e0216956, 2019 (IF:2.776) ＊44. Morinaga Y, Take Y, Sasaki D, Ota K, Kaku N, Uno N, Sakamoto K, Kosai K, Miyazaki T, Hasegawa H, Izumikawa K, Mukae
H, Yanagihara K: Exploring the microbiota of upper respiratory tract during the development of pneumonia in a mouse model.
PLoS One 14(9): e0222589, 2019 (IF:2.776) ＊45. Miyazaki T, Nakamura S, Hashiguchi K, Kobayashi T, Fukushima K, Fukuda Y, Kondo A, Inoue Y, Koga H, Sasaki E, Nagayoshi
Y, Higashiyama Y, Yoshida M, Takazono T, Saijo T, Morinaga Y, Yamamoto K, Imamura Y, Mikushi S, Izumikawa K,
Yanagihara K, Kohno S, Mukae H: The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia inelderly patients: A randomized, multicenter, open-label trial. J Infect Chemother 25(11): 886-893, 2019 (IF:1.539) ＊46. Shimada M, Yamaguchi H, Fukuda M, Tomono H, Honda N, Dotsu Y, Taniguchi H, Gyotoku H, Senju H, Takemoto S, Ikeda T,
Nakatomi K, Nakamura Y, Nagashima S, Yamazaki T, Mukae H: Dose escalation study of amrubicin and cisplatin withconcurrent thoracic radiotherapy for limited-disease small cell lung cancer. Cancer Chemother Pharmacol 84: 1059-1064, 2019
(IF:2.524) ＊47. Tomono H, Soda H, Fukuda Y, Tanaka Y, Ono S, Shimada M, Iwasaki K, Hisanaga M, Yamaguchi H, Mukae H: Intrathoracic
amyloid tumors that presented as yellowish multinodular endobronchial protrusions with irregular vascularity and easy bleeding.
Thorac Cancer 10(10): 2026-2030, 2019 (IF:2.569) ＊48. Noguchi S, Yatera K, Akata K, Chang B, Ikegami H, Hata R, Yamasaki K, Kawanami T, Mukae H: Distribution and annualchanges in the porportion of Streptococcus pneumoniae serotypes in Japanese adult with pneumococcal pneumonia from 2011 to2017. J Infect Chemother 25(11): 925-929, 2019 (IF:1.539) ＊3

49. Yamasue M, Komiya K, Yoshikawa H, Kohno Y, Imamura Y, Otani S, Shigenaga T, Koga H, Kishi K, Ichimiya T, Tanaka H,
Hara K, Noguchi D, Yatera K, Mukae H, Hiramatsu K, Kadota J: Effect of long-term clarithromycin therapy on prevention ofpneumonia in older adults: a randomized, controlled trial. Geriatr Gerontol Int 19(10): 1006-1009, 2019 (IF:2.118) ＊50. Koga S, Takazono T, Ando T, Hayasaka D, Tashiro M, Saijo T, Kurihara S, Sekino M, Yamamoto K, Imamura Y, Miyazaki T,
Yanagihara K, Morita K, Izumikawa K, Mukae H: Severe fever with thrombocytopenia syndrome virus RNA in semen, Japan.
Emerg Infect Dis 25(11): 2127-2128, 2019 (IF:7.185) ＊51. Ota Y, Kitamura M, Muta K, Yamashita H, Uramatsu, Obata Y, Harada T, Funakoshi S, Mukae H, Nishino T: Effect of statin onlife prognosis in Japanese patients undergoing hemodialysis. PLoS One 14(10): e0224111, 2019 (IF:2.776) ＊52. Fukushima C, Matsuse H, Obase Y, Fukahori S, Tsuchida T, Kawano T, Kohno S, Mukae H: Liposomal amphotericin B fosters
the corticosteroids' anti-inflammatory effect on murine allergic bronchopulmonary aspergillosis model airways. Inflammation
42(6): 2065-2071, 2019 (IF:2.939) ＊★
53. Kitamura M, Mochizuki Y, Matsuda T, Mukae Y, Nakanishi H, Ota Y, Uramatsu T, Obata Y, Sakai H, Mukae H and Nishino T:
Sex differences in uric acid levels in kidney transplant recipients and their donors: a preliminary retrospective cross-sectional
study. Ren Replac Ther 5: 47, 2019－54. Torigoe K, Obata Y, Morimoto S, Torigoe M, Oka S, Uramatsu T, Mukae H, Nishino T: Factors associated with gustatory
threshold for salty taste in peritoneal dialysis patients. Ren Replac Ther 5: 38, 2019－55. Shimoda T, Obase Y, Nagasaka Y, Kishikawa R, Asai S: Lung Sound Analysis Provides A Useful Index For Both Airway
Narrowing And Airway Inflammation In Patients With Bronchial Asthma. J Asthma Allergy 12: 323-329, 2019－56. Hanaka T, Kido T, Noguchi S, Yamada S, Noguchi H, Guo X, Nawata A, Wang KY, Oda K, Takaki T, Izumi H, Ishimoto H,
Yatera K, Mukae H: The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis. BMC Pulm
Med 19(1): 265, 2019 (IF:2.184) ＊57. Tachiwada T, Oda K, Tahara M, Sennari K, Nemoto K, Noguchi S, Kawanami T, Kido T, Yamaguchi H, Yatera K: Fatal Acute
Exacerbation of Familial Interstitial Pneumonia Complicated with Dyskeratosis Congenita after Influenza Virus B Infection.
Intern Med 58(18): 2683-2687, 2019 (IF:1.037) ＊58. Aritomi T, Kido T, Nakano K, Satoh Y, Noguchi S, Jotatsu T, Hanaka T, Satoh M, Tanaka Y, Yatera K. Small Cell Lung Cancer
Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful
Chemoradiotherapy. Intern Med 58(3): 427-431, 2019 (IF:1.037) ＊59. Ohue Y, Kurose K, Karasaki T, Isobe M, Yamaoka T, Futami J, Irei I, Masuda T, Fukuda M, Kinoshita A, Matsushita H, Shimizu
K, Nakata M, Hattori N, Yamaguchi H, Fukuda M, Nozawa R, Kakii K, Oka M. Serum antibody against NY-ESO-1 and XAGE1
antigens potentially predicts clinical responses to anti-programmed cell death-1 therapy in NSCLC. J Thorac Oncol 14(12): 207183, 2019 (IF:12.46) ＊60. Maruyama T, Fujisawa T, Ishida T, Ito A, Oyamada Y, Fujimoto K, Yoshida M, Maeda H, Miyashita N, Nagai H, Imamura Y,
Shime N, Suzuki S, Amishima M, Higa F, Kobayashi H, Suga S, Tsutsui K, Kohno S, Brito V, Niederman MS. A Therapeutic
Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter- Cohort Study Using Risk Factors for Multidrug ResistantPathogens To Select Initial Empiric Therapy. Clin Infect Dis 68(7): 1080-1088, 2019 (IF:9.055) ＊61. Tsuchiya T, Matsumoto K, Miyazaki T, Yamaguchi H, Yamazaki T, Sano I, Fukuoka J, Nakamura Y, Yamasaki N, Nagayasu T.
Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer. Gen
Thorac Cardiovasc Surg 67(6):537-543. 2019 (IF:1.219) ＊62. Tsuchiya-Kawano Y, Sasaki T, Yamaguchi H, Hirano K, Horiike A, Satouchi M, Hosokawa S, Morinaga R, Komiya K, Inoue K,
Fujita Y, Toyozawa R, Kimura T, Takahashi K, Nishikawa K, Kishimoto J, Nakanishi Y, Okamoto I. Updated Survival Data fora Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small
Cell Lung Cancer. Oncologist 24:1–7, 2019 (IF:5.252) ＊63. Chiba Y, Kido T, Tahara M, Oda K, Noguchi S, Kawanami T, Yokoyama M, Yatera K. Hard Metal Lung Disease with Favorable
Response to Corticosteroid Treatment: A Case Report and Literature Review. Tohoku J Exp Med 247(1): 51-58, 2019 (IF:1.584)＊
A-b
1. Yatera K, Mukae H: Possible pathogenic roles of nitric oxide in asthma. Respir Investig 57 (4): 295-297, 2019－
2. Kitamura M, Mochizuki Y, Miyata Y, Obata Y, Mitsunari K, Matsuo T, Ohba K, Mukae H, Yoshimura A, Nishino T, Sakai H:
Pathological characteristics of periodontal disease in patients with chronic kidney disease and kidney transplantation. Int J Mol
Sci 20(14): 3413, 2019 (IF:4.183) ＊3. Miyata Y, Obata Y, Mochizuki Y,Kitamura M, Mitsunari K, Matsuo T, Ohba K, Mukae H, Nishino T, Yoshimura A, Sakai H:
Periodontal disease in patients receiving dialysis. Int J Mol Sci 20(15): 3805, 2019 (IF:4.183) ＊

B 邦文
4

B-a
1. 矢田秀雄, 澤井豊光, 古賀 晢, 吉岡寿麻子, 松尾信子, 迎が疑われた 1 例. 日本呼吸器学会誌 8(1): 36-41, 2019

寛: アトルバスタチンやモンテルカストによる薬剤性肺炎

2. 田原正浩, 山﨑 啓, 池上博昭, 福田洋子, 内村圭吾, 立和田 隆, 野口真吾, 川波敏則, 城戸貴志, 迎
帰脾湯による薬剤性肺障害の１例. J UOEH 41(1): 51-56, 2019寛, 矢寺和博: 加味

3. 鈴木一枝, 土屋暁美, 中村絵里花, 川田満栄, 荒川由美子, 野田夏海, 池田津奈子, 長池恵美, 宮崎智子, 橋詰淳哉, 神田絋介, 中村忠博, 本田琢也, 福田 実, 芦澤和人： 看護師による抗がん剤ルート確保の取り組み. 癌と化学療法 46(4): 679683, 2019
4. 尾長谷 靖, 河野哲也, 深堀 範, 坂本憲穂, 松本武浩, 福島千鶴, 迎
肺疾患に関する検討. 長崎医学雑誌 94(2): 110-113, 2019

寛: 当院の術前紹介システムにおける慢性閉塞性5. 松尾信子, 對馬秀樹, 澤井豊光, 赤城和優, 井手昇太郎, 吉岡寿麻子, 迎
し再生不良性貧血と診断した１例. Kekkakku 94(7): 419-423, 2019

寛: 肺結核治療中に、高度の汎血球減少をきた

6. 安東恒史, 今泉芳孝, 山本和子, 田中萌, 財前圭晃, 田口正剛, 榊智佳, 一瀬将広, 古本嵩文, 橋本美紀, 藤岡真知子, 坂本光, 蓬莱真喜子, 糸永英弘, 佐藤信也, 澤山靖, 波多智子, 迎 寛, 福岡順也, 井上大輔, 宮﨑泰司: 副甲状腺切除後に異所性肺石灰化を認めた多発性骨髄腫. 臨床血液 60(7): 785-790, 2019
7. 依田彩文, 中道聖子, 松原 大, 長浦由紀, 山梨啓友, 坂本憲穂, 安倍邦子, 大園惠幸, 前田隆浩: A Case of Sarcoidosis
Diagnosed After Detection of High Serum Carbohydrate Antigen 19-9 Levels. 日本病院総合診療医学会雑誌 15: 73-77, 20198. 石岡泰知, 山本和子, 井手口周平, 梅村明日香, 高園貴弘, 西條知見, 今村圭文, 宮崎泰可, 井上大輔, 迎症した眼結核症の２例. Kekkaku 94(10): 497-502, 20199. 上野芙央, 浦松 正, 崎村直史, 山下鮎子, 太田祐樹, 北村峰昭, 小畑陽子, 坂本憲穂, 迎した急性肉芽腫性間質性腎炎の 1 例. 長崎医学会雑誌 94(3): 153-158, 2019

寛：飛蚊症で発寛, 西野友哉: 原因検索に苦慮

B-b
1. 山口 博之, 福田実: 脳転移に有効な薬物療法の開発. Medical practice 36(2): 267-269, 2019

2. 石本裕士: 間質性肺炎の増悪・急性間質性肺炎. 内科 123(1): 95-98, 2019
3. 石本裕士: 経ステロイド（間質性肺炎）. 内科 123(3): 379-382, 2019
4. 山本和子, 迎

寛: １ペニシリン系抗菌薬

実践的感染症診療. Medical Practice 臨時増刊号 36: 54-60, 2019

5. 迎

寛：呼吸器疾患と膠原病. Medical practice 36(6):982, 2019.

6. 迎

寛: 特集

高齢者肺炎の見極めと治療のポイント

7. 赤田憲太朗, 野口真吾, 川波敏則, 畑
UOEH 41(2): 185-192, 20198. 石本裕士, 迎
9. 迎

亮輔, 内藤圭祐, 迎寛, 矢寺和博: 誤嚥性肺炎の病態および原因菌について. J

寛: 間質性肺炎の診断で注意するポイント. 臨床と研究 96 (7): 855-859, 2019

寛: 咳嗽セクションの改定のポイント. 呼吸器ジャーナル 67(3): 544-545, 201910. 尾長谷 靖、迎11. 迎監修. 日本医事新報 4959: 17, 2019

寛: 咳嗽の成り立ちから見た治療戦略. 呼吸器内科 36(4): 334-340, 2019

寛: 咳・痰のガイドライン. NHK テキストきょうの健康 11: 108-112, 201912. 平山達朗、迎 寛: インフルエンザ

外来で診る高齢者感染症. 臨床と研究 96(12): 1366-1370, 201913. 平山達朗, 宮崎泰可: 肺真菌症 カンジダ. 感染と抗菌薬 22(4): 270-275, 201914. 高園貴弘：質疑応答プロからプロへ
日本医事新報 4992: 62-62, 2019アレルギー性気管支肺アスペルギルス症の現在の考え方と治療法について.

15. 尾長谷 靖：「咳嗽・喀痰の診療ガイドライン 2019」の特徴と概要は？

日本医事新報 4983: 53-54, 201916. 住吉 誠, 宮崎泰可: 肺炎. 月刊薬事 61(16): 27-32, 2019
17. 今村圭文: 高齢者肺炎の治療とポイント. 日本医事新報 4959: 30-36, 201918. 田代将人、泉川公一：[実践的]感染症診療19. 田代将人：目で見るトレーニング
2019

カンジダ症．Medical Practice 36 増刊号：337-340, 2019

問題 899アレルギー性気管支肺アスペルギルス症. Medicina 56(1): 170-175,5

20. 田代将人：目で見るトレーニング

問題 904 単純性肺アスペルギローマ. Medicina 56(3): 548-554, 201921. 田代将人：目で見るトレーニング

問題 911 侵襲性肺アスペルギルス症. Medicina 56(6): 961-966, 201922. 田代将人：浮遊真菌とリザーバー INFECTION CONTROL

22(4): 270-275, 2019

B-c
1. 迎

寛（委員長）、尾長谷靖（事務局）：日本呼吸器学会

咳嗽・喀痰の診療ガイドライン 2019, 2019

2. 迎

寛: 肺真菌症. 今日の治療指針 2019 年版: 294-295, 2019

3. 迎

寛: クラミジア（クラミドフィラ）・ニューモニエ感染症. 今日の治療指針 2019 年版: 213-214, 2019

4. 迎

寛: 感染症における宿主と微生物の反応. 中山書店改訂第９版内科学書: 11-12, 2019

5. 迎

寛: 寄生虫性肺疾患１原虫肺疾患・２蠕虫肺疾患. 中山書店改訂第９版内科学書: 462-463, 2019

6. 矢寺和博, 迎寛: 肺炎の原因菌の遺伝子診断. 臨床呼吸器感染症学: 41-45, 2019

7. 野口真吾, 迎

寛: 医療・介護関連肺炎治療の考え方と実践. 臨床呼吸器感染症学: 153-168, 20198. 川波敏則, 迎寛: 胸膜炎. 臨床呼吸器感染症学: 208-212, 20199. 松元信弘, 迎

寛: 寄生虫性肺疾患. 臨床呼吸器感染症学: 261-270, 201910. 城戸貴志, 迎

寛: じん肺症. 気管支鏡テキスト 改訂第 3 版: 254-255, 201911. 髙園貴弘, 迎

寛: 1361 専門家による私の治療 2019-20 年度版.S3-12 肺真菌症. 日本医事新報, 201912. 高園貴弘, 山本和子：臨床呼吸器感染症学

市中肺炎治療の考え方と実践, 201913. 山本和子. IV.ガイドラインに基づく肺炎診療の実際. 2.市中肺炎治療の考え方と実践. G.補助療法. H.その他考慮すべき市中肺炎. 臨床呼吸器感染症学: 139-152, 201914. 伊藤裕也, 宮崎泰可: 肺真菌症. 臨床呼吸器感染症学: 245-255, 201915. 宮崎泰可: 伝染性単核球症. 今日の治療指針 2019 年版: 231-232, 2019
16. 今村圭文: 肺炎診療ガイドラインに基づく肺炎の分類と診療の考え方. 臨床呼吸器感染症学: 114-124, 201917. 田代将人. 感染経路別予防策. 臨床呼吸器感染症学: 295-301, 201918. 西條知見, 迎寛: 抗菌薬. 呼吸器疾患

最新の治療 2019-2020: 98-104, 2019B-d
1. 山本和子: マクロファージ免疫応答に着目した肺炎球菌肺炎の病態の解明と新しい治療法の開発. 平成 30 年度長崎医学同窓会医学研究助成金・研究成果報告. 長崎県医師会報平成 31 年 3 月号: 7-8, 2019

論文研究業績集計表
論文数一覧
2019

A-a
63

A-b
3

A-c
0

A-d
0

A-e
0

合計
66

SCI
59

B-a
9

B-b
22

B-c
18

学会発表数一覧
A-a
2019

A-b
ｼﾝﾎﾟｼﾞｳﾑ

0

0

A-b
学会
11

合計

B-a

11

8

B-b
学会
187

B-a
ｼﾝﾎﾟｼﾞｳﾑ

19

合計

総計

214

225

論文総数に係る教員生産係数一覧

2019

欧文論文総数
論文総数

教員生産係数（欧文論文）SCI 掲載論文数
欧文論文総数

教員生産係数（SCI 掲載論文）

0.569

5.500

0.894

4.917

Impact factor 値一覧
Impact factor
2019
187.152

教員当たり Impact factor
15.596

論文当たり Impact factor
3.172

6

B-d
1

B-e
0

合計
50

総計
116